201 related articles for article (PubMed ID: 33976347)
1. DNA repair proteins may differentiate papillary thyroid cancer from chronic lymphocytic thyroiditis and nodular colloidal goiter.
Evren B; Yılmaz S; Karadağ N; Sertkaya AÇ; Topaloğlu Ö; Kılınç F
Sci Rep; 2021 May; 11(1):9932. PubMed ID: 33976347
[TBL] [Abstract][Full Text] [Related]
2. Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: an immunohistochemical study.
Giaginis C; Michailidi C; Stolakis V; Alexandrou P; Tsourouflis G; Klijanienko J; Delladetsima I; Theocharis S
Med Sci Monit; 2011 Feb; 17(3):BR81-90. PubMed ID: 21358597
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions.
Cooper WA; Kohonen-Corish MR; Chan C; Kwun SY; McCaughan B; Kennedy C; Sutherland RL; Lee CS
Histopathology; 2008 Apr; 52(5):613-22. PubMed ID: 18370958
[TBL] [Abstract][Full Text] [Related]
4. Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.
Stark AM; Doukas A; Hugo HH; Hedderich J; Hattermann K; Maximilian Mehdorn H; Held-Feindt J
Neurol Res; 2015 Feb; 37(2):95-105. PubMed ID: 24995467
[TBL] [Abstract][Full Text] [Related]
5. Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis Than with Multinodular Goiter or Graves' Disease.
Paparodis RD; Karvounis E; Bantouna D; Chourpiliadis C; Chourpiliadi H; Livadas S; Imam S; Jaume JC
Thyroid; 2020 Apr; 30(4):531-535. PubMed ID: 31950881
[No Abstract] [Full Text] [Related]
6. Expression of cytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reaction.
Flanagan JN; Pineda P; Knapp PE; De Las Morenas A; Lee SL; Braverman LE
Endocr Pract; 2008 Mar; 14(2):168-74. PubMed ID: 18308654
[TBL] [Abstract][Full Text] [Related]
7. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
J Oral Pathol Med; 2011 Mar; 40(3):218-26. PubMed ID: 21029181
[TBL] [Abstract][Full Text] [Related]
8. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].
Tong J; Wang Y; Da JP
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220
[TBL] [Abstract][Full Text] [Related]
10. The reliability of fine-needle aspiration biopsy in terms of malignancy in patients with Hashimoto thyroiditis.
Kapan M; Onder A; Girgin S; Ulger BV; Firat U; Uslukaya O; Oguz A
Int Surg; 2015 Feb; 100(2):249-53. PubMed ID: 25692426
[TBL] [Abstract][Full Text] [Related]
11. [Detection of cytokeratin 19 and thyroperoxidase expressions in the diagnosis of thyroid diseases].
Yang QX; Shao CK; Feng ZY; Huang BQ; Han AJ; Xiong M; Zhao WL; Wu TT
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):678-81. PubMed ID: 15958307
[TBL] [Abstract][Full Text] [Related]
12. Study of autophagy-related protein light chain 3 (LC3)-II expression levels in thyroid diseases.
Zhang N; Li L; Wang J; Cao M; Liu G; Xie G; Yang Z; Li Y
Biomed Pharmacother; 2015 Feb; 69():306-10. PubMed ID: 25661375
[TBL] [Abstract][Full Text] [Related]
13. THYROID OPERATIONS. A REVIEW OF 364 CONSECUTIVE CASES.
JOHNSON JR
Calif Med; 1965 Mar; 102(3):194-8. PubMed ID: 14254976
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
Pyo JS; Kim DH; Yang J
Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of thyroid fine-needle aspirations: can ThinPrep be used exclusively to appropriately triage patients having a thyroid nodule?
Duncan LD; Forrest L; Law WM; Hubbard E; Stewart LE
Diagn Cytopathol; 2011 May; 39(5):341-8. PubMed ID: 21488177
[TBL] [Abstract][Full Text] [Related]
16. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: An analysis of hOGG1 loss of heterozygosity.
Royer MC; Zhang H; Fan CY; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):240-2. PubMed ID: 20231640
[TBL] [Abstract][Full Text] [Related]
18. False-positive cytopathology results for papillary thyroid carcinoma: A trap for thyroid surgeons.
Yi KI; Ahn S; Park DY; Lee JC; Lee BJ; Wang SG; Cha W
Clin Otolaryngol; 2017 Dec; 42(6):1153-1160. PubMed ID: 28130940
[TBL] [Abstract][Full Text] [Related]
19. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases.
Bradly DP; Reddy V; Prinz RA; Gattuso P
Surgery; 2009 Dec; 146(6):1099-104. PubMed ID: 19958937
[TBL] [Abstract][Full Text] [Related]
20. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions.
Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G
Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
